Efficacy of beta-lapachone in pancreatic cancer treatment: Exploiting the novel, therapeutic target NQO1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of beta-lapachone in pancreatic cancer treatment: Exploiting the novel, therapeutic target NQO1

Published:2005-01 Issue:1 Volume:4 Page:102-109
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Ough Matthew,Lewis Anne,Bey Erik A.,Gao Jinming,Ritchie Justine M.,Bornmann William,Boothman David A.,Oberley Larry W.,Cullen Joseph J.

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.4.1.1382

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human NQO1 as a Selective Target for Anticancer Therapeutics and Tumor Imaging;Cells;2024-07-29

2. Anticancer Potential and Safety Profile of β-Lapachone In Vitro;Molecules;2024-03-21

3. Anti-inflammatory and antiproliferative activity of Helichrysum odoratissimum Sweet. against lung cancer;South African Journal of Botany;2024-03

4. NAD(P)H:Quinone Acceptor Oxidoreductase 1 (NQO1) Activatable Salicylamide H⁺/Cl⁻ Transporters;Chemistry – A European Journal;2023-08-09

5. Miscellany of Chromene;The Role of Chromenes in Drug Discovery and Development;2023-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP